IVOS Medical Joins NIH’s C3i Program to Accelerate Commercialization of BOSS G4™ Airway Management Technology
Selection underscores innovation in airway safety and NIH’s support for advancing life-saving medical devices from lab to market
The medical device space is growing rapidly as new startups and investments from major players enter the market. Some of the most notable investors in medical devices include venture capital firms such as Kleiner Perkins Caufield & Byers, Sequoia Capital, and Accel Partners, as well as large companies such as Johnson & Johnson and Medtronic.
This influx of investment is driving innovation in the medical device space, with new devices and treatments being developed all the time. This growth is also creating opportunities for entrepreneurs, who can now launch their own medical device startups and access funding from major players.
Selection underscores innovation in airway safety and NIH’s support for advancing life-saving medical devices from lab to market
The device demonstrated consistent accuracy even when the arm was positioned below heart level, meeting the rigorous validation requirements set by the European Society of Hypertension (ESH).
The complementary AI agent will conduct first-of-its-kind automated outreach on behalf of health systems via voice and SMS for ACA Re-Enrollment & Medicaid Redetermination (ARMR™)—driving patient awareness, successful re-enrollment, and protected revenue
The updated NICE guidelines include topical oxygen therapy as an adjunct to standard care for diabetic foot ulcers that are not responding to treatment, reflecting increasing recognition from national health authorities of the clinical value and potential of TWO2® therapy to improve outcomes in difficult-to-heal wounds
Vizient, the nation’s largest provider-driven healthcare performance improvement company, will hold the Exchange Sept. 17 in Las Vegas
As clinical research becomes increasingly globalized, Belgium and France are expected to play an even greater role. Their complementary strengths make them attractive not just for European sponsors but for companies worldwide seeking reliable partners.